Drugs / cindunistat
cindunistat
also known as
CINDUNISTAT HYDROCHLORIDE MALEATE · PF-00572986 · PHA-728669F · PHA-84250 · SC-084250 · SD-6010
Small molecule targets NOS2 via inhibition
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00565812 Comparator | Nov 2007 → Oct 2011 | osteoarthritis | Pfizer | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cindunistat | “selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic” PMID 23144445 ↗ Nov 2012 |
| Known as | CINDUNISTAT HYDROCHLORIDE MALEATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3040926 ↗ |
| Known as | PF-00572986 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3040926 ↗ |
| Known as | PHA-728669F | ChEMBL registry synonym — accepted as the source's own label CHEMBL3040926 ↗ |
| Known as | PHA-84250 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3040926 ↗ |
| Known as | SC-084250 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3040926 ↗ |
| Known as | SD-6010 | “selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic” PMID 23144445 ↗ Nov 2012 |
| Action | Inhibit | “inhibition of inducible nitric oxide synthase (iNOS)” PMID 23144445 ↗ Nov 2012 |
| Modality | Small molecule | — CHEMBL3040926 ↗ |
| Route | Oral | “Orally Administered SD-6010” NCT00565812 ↗ |
| Target | NOS2 | “inhibitor of inducible nitric oxide synthase (iNOS)” NCT00565812 ↗ |